29. September 2015
Pure gliadin peptides, recombinantly produced as easy-to-handle fusion with a carrier protein are now available.
In addition we provide antibodies to gliadin and cereal protein extracts like wheat gliadin for your research.
Find below the selection of our Recombinant Gliadin Peptides:
Albumin + globulin, prolamin and glutelin extracts from the cereals listed below are available: www.zedira.com/Cereal-Proteins.
Document
New: Recombinant Gliadin Peptides
Pure gliadin peptides, recombinantly produced as easy-to-handle fusion with a carrier protein are now available.
In addition we provide antibodies to gliadin and cereal protein extracts like wheat gliadin for your research.
Find below the selection of our Recombinant Gliadin Peptides:
| Art. No. | Name | Unit | Price | |||||
| G051 | 26mer γ-gliadin peptide |  |
250 µg | 370 € | ||||
| G052 | 33mer α-gliadin peptide |  |
250 µg | 370 € | ||||
| G055 | Carrier protein control |  |
250 µg | 370 € | ||||
| G053 | 26mer DGP (DGPx1) |  |
250 µg | 370 € | ||||
| G054 | 33mer DGP |  |
250 µg | 370 € | ||||
| G006 | DGPx2 |  |
500 µg | 735 € | ||||
| G005 | DGPx4 |  |
500 µg | 735 € | ||||
| G056 |
DGP and Gliadin peptides (Set No 1) (G051, G052, G053, G054 and G055, 100 µg each) |
1 Set | 740 € | |||||
Corresponding research tools: Antibodies to gliadin |
||||||||
| Art. No. | Name | Unit | Price | |||||
| A011 |
Monoclonal antibody to gliadin (clone XGY1) (recognizes 26mer γ-gliadin peptide [G051], but not 33mer α-gliadin) |
1 mg | 365 € | |||||
| A064 |
Monoclonal antibody to gliadin (clone XGY4) (recognizes 26mer γ-gliadin peptide [G051], and 33mer α-gliadin [G052] and corresponding DGP’s [G053, G054, G006, G005]) |
1 mg | 365 € | |||||
| A057 |
Monoclonal antibody to deamidated Gliadin (specific to 33mer DGP [G054]) |
100 µg | 480 € | |||||
| Find further antibodies against gliadin and deamidated gliadin on our website www.zedira.com/Antibodies/Wheat-Gliadin. Cereal Proteins |
||||||||
| Art. No. | Name | Unit | Price | |||||
| G037 | Wheat prolamin (Gliadin) | 5 mg | 195 € | |||||
Document
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
Press release: Zedira announces ISO 9001:2015 certification
Zedira communication: Joint poster presentation on “Feasibility of a new automated FXIII activity assay”
Artikel in DZG Aktuell 01/2019 über die klinische Wirksamkeitsstudie unseres potentiellen Zöliakie Medikaments (deutsch)
Preview: Catalogue Editorial 2019
Design of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering
Tridegin as FXIIIa inhibitor
Microbial transglutaminase: from discovery to market
Tissue transglutaminase inhibitors
Tissue transglutaminase in Alzheimer’s Disease
Factor XIIIa: novel target for anticoagulation?
Microbial transglutaminase for site-specific protein conjugation
Transglutaminase antibodies in ataxia